Enzymes: Stereospecificity and Catalysis Revision Notes | A Level AQA Chemistry

1. Enzymes as Proteins: The Structural Foundation of Catalysis

Picture a lock and key. The lock has a precise shape — only one specific key fits. Enzymes work on exactly this principle, and understanding why requires starting with what enzymes actually are: proteins.

Enzymes are proteins that act as biological catalysts. Their primary structure — the sequence of amino acids — determines how the polypeptide chain folds into a precise three-dimensional tertiary structure. It is this three-dimensional shape that gives an enzyme its catalytic power. Some enzymes also require non-protein cofactors (such as metal ions or coenzymes) for full activity, but the protein component is essential for forming the specific active site.

Within that three-dimensional structure lies the active site: a small, specifically shaped region where the substrate molecule binds. The active site is not a passive pocket — it is lined with amino acid residues whose side chains (R groups) carry particular charges, polarities, and spatial orientations. These features allow the active site to form temporary bonds with a substrate, holding it in exactly the right position for the reaction to proceed.

Bridge: the sequence primary structure -> tertiary structure -> active-site geometry is the reason enzyme catalysis and stereospecificity must be explained together rather than as separate facts.

When a substrate enters the active site, the enzyme may undergo a slight conformational change to optimise the fit — this is the induced fit model. The result is an enzyme–substrate complex in which the substrate is strained or oriented so that the activation energy of the reaction is lowered. The enzyme is then released unchanged, ready to catalyse the next reaction.

2. Stereospecificity: Why Only One Mirror Image Fits

Here is where it gets genuinely interesting. Many biologically important molecules — amino acids, sugars, and numerous drugs — are chiral. A chiral molecule has a carbon atom bonded to four different groups, meaning it exists as two non-superimposable mirror images called enantiomers.

Enantiomers have identical molecular formulae and the same connectivity of atoms. Their physical properties — melting point, boiling point, solubility — are identical in an achiral environment. The only difference is the spatial arrangement of groups around the chiral centre.

Now consider the active site of an enzyme. Because the active site is built from L-amino acids arranged in a precise three-dimensional architecture, it is itself a chiral environment. The functional groups within the active site point in specific directions in three-dimensional space. This means the active site can distinguish between enantiomers — it is stereospecific.

Think of it this way: imagine a glove. A left-hand glove fits a left hand perfectly — every finger aligns. A right hand has the same fingers and the same dimensions, but the spatial arrangement is mirrored, so the glove does not fit. The active site is the glove; the two enantiomers are the two hands.

For a substrate to bind productively to the active site, it must simultaneously satisfy multiple spatial constraints: the correct groups must align with the correct residues at the correct positions. The wrong enantiomer may be able to enter the active site partially, but it cannot form all the necessary interactions at once because its groups point in the wrong directions. No productive enzyme–substrate complex forms, so no catalysis occurs.

3. Visualising the Stereospecific Interaction

To make this concrete, consider a chiral substrate with a chiral centre bearing four different groups: $-NH_2$, $-COOH$, $-H$, and $-R$ (a side chain). The two enantiomers, conventionally labelled L and D, have these groups arranged as mirror images around the central carbon.

The active site contains three key residues positioned in space: one that forms a hydrogen bond with $-NH_2$, one that forms an ionic interaction with $-COOH$, and one that provides a hydrophobic pocket for $-R$. For the L-enantiomer, all three groups align simultaneously with their corresponding residues — a productive complex forms. For the D-enantiomer, rotating or flipping the molecule to align one group inevitably misaligns the others. The three-point interaction cannot be satisfied, so binding is non-productive.

This three-point interaction model is a useful way to reason about stereospecificity in exam answers. It explains not just that the wrong enantiomer fails to bind, but why: the simultaneous satisfaction of multiple spatial constraints is impossible when the three-dimensional arrangement is mirrored.

4. Stereospecificity and Drug Action

The same principle that governs substrate binding applies directly to drugs. Many pharmaceutical compounds are chiral, and their two enantiomers can have dramatically different effects in the body — because biological receptors and enzymes are themselves chiral environments.

Consider a drug designed to inhibit a specific enzyme. The drug molecule must bind to the active site in a way that blocks substrate access or prevents catalysis. If the drug is chiral, only the enantiomer with the correct spatial configuration will form the necessary interactions with the active site residues. The other enantiomer may be pharmacologically inactive, or in some cases may produce unwanted effects by interacting with a different biological target.

A historically significant example is thalidomide, a drug prescribed in the late 1950s. One enantiomer had the intended therapeutic effect; the other was associated with severe developmental harm. Both enantiomers were present in the racemic mixture that was administered. It is important to note, however, that thalidomide enantiomers interconvert rapidly in the body (racemise in vivo), meaning that administering only one enantiomer would not have prevented the harm in this specific case. Nevertheless, the thalidomide case illustrates the principle that the stereospecificity of biological systems can have profound practical consequences — and it prompted modern drug development to pay close attention to chirality, particularly for drugs where enantiomers do not interconvert.

For AQA purposes, the key point is this: a stereospecific active site can only bond to one enantiomeric form of a drug because the active site's three-dimensional arrangement of functional groups is complementary to only one spatial configuration. The other enantiomer cannot simultaneously satisfy the spatial and chemical requirements of the active site.

5. Enzyme Catalysis: The Mechanism in Context

Bringing the ideas together: enzymes are proteins whose tertiary structure creates a stereospecific active site. When the correct enantiomer of a substrate binds, an enzyme–substrate complex forms. The active site stabilises the transition state of the reaction, lowering the activation energy and allowing the reaction to proceed at a rate sufficient for biological processes.

The enzyme is not consumed in the reaction. After the products are released, the active site is free to bind another substrate molecule. The stereospecificity of the active site means this process is selective: only the substrate (or drug) with the correct three-dimensional configuration will be processed.

Worked example: Explaining Stereospecific Enzyme Catalysis in an Exam Answer

Explain why an enzyme can catalyse the reaction of one enantiomer of a substrate but not the other. [4 marks]

1. Enzymes are proteins whose tertiary structure is determined by the sequence of amino acids. — [B1] — This is a standalone fact that underpins everything that follows. State it explicitly.
2. The active site has a precise three-dimensional arrangement of functional groups, formed from L-amino acids, making it a chiral environment. — [B1] — The chirality of the active site is the key mechanistic point. Examiners want to see 'three-dimensional arrangement' or equivalent language.
3. One enantiomer has the correct spatial configuration so that its functional groups align simultaneously with the complementary groups in the active site, forming an enzyme–substrate complex. — [B1] — Use 'simultaneously' and 'complementary' — these are mark-winning words. The idea of multiple simultaneous interactions is what distinguishes a good answer.
4. The other enantiomer is a non-superimposable mirror image; its groups point in the wrong directions relative to the active site residues, so it cannot satisfy all the spatial constraints simultaneously and no productive enzyme–substrate complex forms. — [B1] — Explicitly state that the mirror-image arrangement prevents simultaneous satisfaction of all binding requirements. Do not just say 'it does not fit' — explain why.

Answer: Enzymes are proteins with a precise three-dimensional active site formed from L-amino acids, making it a chiral environment. One enantiomer has the correct spatial configuration to align its functional groups simultaneously with the complementary residues in the active site, forming a productive enzyme–substrate complex and allowing catalysis. The other enantiomer, being a non-superimposable mirror image, cannot simultaneously satisfy all the spatial constraints of the active site, so no productive complex forms and no catalysis occurs.

6. Exam Technique and Common Mistakes

AQA questions on this topic tend to use 'explain' as the command word, which means you must give reasons — not just describe what happens. The distinction between a weak answer and a mark-winning answer almost always comes down to whether you have explained the three-dimensional spatial argument, not just stated that the enzyme is specific.

The core thread running through this entire topic is the relationship between protein structure and function. Enzymes are proteins; their three-dimensional structure creates a stereospecific active site; that stereospecificity means only one enantiomeric form of a substrate or drug can bind productively. Every exam question on this topic, whether it asks you to describe, explain, or evaluate, is testing whether you can articulate that chain of reasoning with precision.